3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
22 23 0 0 0 0 0 0 0999 V2000
-2.7322 0.2774 0.3075 S 0 0 0 0 0 0 0 0 0 0 0 0
0.9917 -1.9873 0.0771 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.0866 -1.0800 0.6788 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1923 1.2043 1.2849 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3081 -1.7332 -0.3429 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.0638 1.0046 -0.4685 N 1 0 0 0 0 0 0 0 0 0 0 0
-1.6029 0.1959 -1.0525 C 1 0 0 0 0 0 0 0 0 0 0 0
-0.3499 -0.4192 -0.5831 C 1 0 0 0 0 0 0 0 0 0 0 0
0.8847 0.2114 -0.3350 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7010 -0.8256 0.0816 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4139 1.5083 -0.4069 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0365 -0.6757 0.4430 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7568 1.6961 -0.0505 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5510 0.6229 0.3666 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0642 -0.4026 -1.8444 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.4433 1.2137 -1.4205 H 0 0 0 0 0 0 0 0 0 0 0 0
0.8094 2.3509 -0.7275 H 0 0 0 0 0 0 0 0 0 0 0 0
3.6440 -1.5129 0.7645 H 0 0 0 0 0 0 0 0 0 0 0 0
3.1870 2.6933 -0.0988 H 0 0 0 0 0 0 0 0 0 0 0 0
4.5891 0.8009 0.6367 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.9834 1.9946 -0.7312 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.5925 0.4389 -1.1439 H 0 0 0 0 0 0 0 0 0 0 0 0
1 3 2 0 0 0 0
1 4 2 0 0 0 0
1 6 1 0 0 0 0
1 7 1 0 0 0 0
2 5 1 0 0 0 0
2 10 1 0 0 0 0
5 8 2 0 0 0 0
6 21 1 0 0 0 0
6 22 1 0 0 0 0
7 8 1 0 0 0 0
7 15 1 0 0 0 0
7 16 1 0 0 0 0
8 9 1 0 0 0 0
9 10 1 0 0 0 0
9 11 2 0 0 0 0
10 12 2 0 0 0 0
11 13 1 0 0 0 0
11 17 1 0 0 0 0
12 14 1 0 0 0 0
12 18 1 0 0 0 0
13 14 2 0 0 0 0
13 19 1 0 0 0 0
14 20 1 0 0 0 0
M ISO 3 6 15 7 13 8 13
4. 国际命名与标识
4.1 IUPAC Name
1,2-benzoxazol-3-yl(113C)methane(15N)sulfonamide
4.2 InChl
InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)/i5+1,7+1,9+1
4.3 InChlKey
UBQNRHZMVUUOMG-VDWPWFDKSA-N
4.4 Canonical SMILES
C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N
4.5 lsomeric SMILES
C1=CC=C2C(=C1)[13C](=NO2)[13CH2]S(=O)(=O)[15NH2]
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病